Kay Friedrichs
About
In The Last Decade
Kay Friedrichs
32 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 92
- Oncology 674
- Molecular Biology 521
- Cancer Research 479
- Cell Biology 244
- Immunology and Allergy 203
Countries citing papers authored by Kay Friedrichs
This map shows the geographic impact of Kay Friedrichs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Friedrichs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Friedrichs more than expected).
Fields of papers citing papers by Kay Friedrichs
This network shows the impact of papers produced by Kay Friedrichs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Friedrichs. The network helps show where Kay Friedrichs may publish in the future.
Co-authorship network of co-authors of Kay Friedrichs
This figure shows the co-authorship network connecting the top 25 collaborators of Kay Friedrichs. A scholar is included among the top collaborators of Kay Friedrichs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Friedrichs. Kay Friedrichs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 3 | |
| 3 | 22 | |
| 4 | 29 | |
| 5 | 30 | |
| 6 | 116 | |
| 7 | 79 | |
| 8 | 21 | |
| 9 | 100 | |
| 10 | Topoisomerase II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated with single-agent doxorubicin or single-agent docetaxel | 40 |
| 11 | 121 | |
| 12 | p-53 gene mutations as a predictive marker in advanced breast cancer patients randomly treated either with doxorubicin or with docetaxel | 2 |
| 13 | 60 | |
| 14 | 14 | |
| 15 | 8 | |
| 16 | 15 | |
| 17 | High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. | 163 |
| 18 | 189 | |
| 19 | 13 | |
| 20 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.